494 related articles for article (PubMed ID: 24745674)
41. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
42. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
Alvarez-Twose I; González de Olano D; Sánchez-Muñoz L; Matito A; Esteban-López MI; Vega A; Mateo MB; Alonso Díaz de Durana MD; de la Hoz B; Del Pozo Gil MD; Caballero T; Rosado A; Sánchez Matas I; Teodósio C; Jara-Acevedo M; Mollejo M; García-Montero A; Orfao A; Escribano L
J Allergy Clin Immunol; 2010 Jun; 125(6):1269-1278.e2. PubMed ID: 20434205
[TBL] [Abstract][Full Text] [Related]
43. Disease Spectrum of Anaphylaxis Disorders.
González de Olano D; Cain WV; Bernstein JA; Akin C
J Allergy Clin Immunol Pract; 2023 Jul; 11(7):1989-1996. PubMed ID: 37220812
[TBL] [Abstract][Full Text] [Related]
44. How I treat patients with indolent and smoldering mastocytosis (rare conditions but difficult to manage).
Pardanani A
Blood; 2013 Apr; 121(16):3085-94. PubMed ID: 23426950
[TBL] [Abstract][Full Text] [Related]
45. Systemic mastocytosis presenting as intraoperative anaphylaxis with atypical features: a report of two cases.
Bridgman DE; Clarke R; Sadleir PH; Stedmon JJ; Platt P
Anaesth Intensive Care; 2013 Jan; 41(1):116-21. PubMed ID: 23362901
[TBL] [Abstract][Full Text] [Related]
46. Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis.
Alvarez-Twose I; Vañó-Galván S; Sánchez-Muñoz L; Morgado JM; Matito A; Torrelo A; Jaén P; Schwartz LB; Orfao A; Escribano L
Allergy; 2012 Jun; 67(6):813-21. PubMed ID: 22458675
[TBL] [Abstract][Full Text] [Related]
47. Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes.
Polivka L; Madrange M; Bulai-Livideanu C; Barete S; Ballul T; Neuraz A; Greco C; Agopian J; Brenet F; Dubreuil P; Burdet C; Lemal R; Tournilhac O; Terriou L; Launay D; Bouillet L; Gourguechon C; Damaj G; Frenzel L; Meni C; Bouktit H; Collange AF; Gaudy-Marqueste C; Gousseff M; Le Mouel E; Hamidou M; Neel A; Ranta D; Jaussaud R; Guilpain P; Canioni D; Molina TJ; Bruneau J; Lhermitte L; Garcelon N; Javier RM; Pelletier F; Castelain F; Retornaz F; Cabrera Q; Zunic P; Gourin MP; Wierzbicka-Hainaut E; Viallard JF; Lavigne C; Hoarau C; Durieu I; Heiblig M; Dimicoli-Salazar S; Torregrosa-Diaz JM; Soria A; Arock M; Lortholary O; Bodemer C; Hermine O; Rossignol J;
J Allergy Clin Immunol; 2024 Jan; 153(1):349-353.e4. PubMed ID: 37633651
[TBL] [Abstract][Full Text] [Related]
48. Drug allergy in mast cell disease.
Brockow K; Bonadonna P
Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):354-60. PubMed ID: 22744266
[TBL] [Abstract][Full Text] [Related]
49. Mastocytosis - an update.
Amon U; Hartmann K; Horny HP; Nowak A
J Dtsch Dermatol Ges; 2010 Sep; 8(9):695-711; quiz 712. PubMed ID: 20678151
[TBL] [Abstract][Full Text] [Related]
50. Childhood mastocytosis.
Torrelo A; Alvarez-Twose I; Escribano L
Curr Opin Pediatr; 2012 Aug; 24(4):480-6. PubMed ID: 22790101
[TBL] [Abstract][Full Text] [Related]
51. Mastocytosis in children: a single-center long-term follow-up study.
Popadic S; Lalosevic J; Lekic B; Gajić-Veljic M; Bonaci-Nikolic B; Nikolic M
Int J Dermatol; 2023 May; 62(5):616-620. PubMed ID: 36807903
[TBL] [Abstract][Full Text] [Related]
52. Clinical aspects of paediatric mastocytosis: a review of 101 cases.
Lange M; Niedoszytko M; Renke J; Gleń J; Nedoszytko B
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):97-102. PubMed ID: 22126331
[TBL] [Abstract][Full Text] [Related]
53. Higher mast cell load decreases the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis.
van Anrooij B; van der Veer E; de Monchy JG; van der Heide S; Kluin-Nelemans JC; van Voorst Vader PC; van Doormaal JJ; Oude Elberink JN
J Allergy Clin Immunol; 2013 Jul; 132(1):125-30. PubMed ID: 23498593
[TBL] [Abstract][Full Text] [Related]
54. Systemic mastocytosis: A cohort study on clinical characteristics of 136 patients in a large tertiary centre.
Hermans MAW; Rietveld MJA; van Laar JAM; Dalm VASH; Verburg M; Pasmans SGMA; Gerth van Wijk R; van Hagen PM; van Daele PLA
Eur J Intern Med; 2016 May; 30():25-30. PubMed ID: 26809706
[TBL] [Abstract][Full Text] [Related]
55. Mast cell activation syndrome: High frequency of skin manifestations and anaphylactic shock.
Casassa EA; Mailhol C; Tournier E; Laurent C; Degboe Y; Eischen M; Kirsten N; Moreau J; Evrard SM; Mansat-De Mas V; Lamant L; Dubreuil P; Apoil PA; Hermine O; Paul C; Bulai Livideanu C
Allergol Int; 2019 Jan; 68(1):119-121. PubMed ID: 30097253
[No Abstract] [Full Text] [Related]
56. Mast cell activation syndromes presenting as anaphylaxis.
Akin C
Immunol Allergy Clin North Am; 2015 May; 35(2):277-85. PubMed ID: 25841551
[TBL] [Abstract][Full Text] [Related]
57. Co-localization of tryptase and cathepsin-G in mast cells in cutaneous mastocytosis.
Ribatti D; Nico B; Finato N; Crivellato E; Beltrami CA
Cancer Lett; 2009 Jul; 279(2):209-12. PubMed ID: 19250736
[TBL] [Abstract][Full Text] [Related]
58. Biology, classification and treatment of human mastocytosis.
Valent P
Wien Klin Wochenschr; 1996; 108(13):385-97. PubMed ID: 8766423
[TBL] [Abstract][Full Text] [Related]
59. Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease.
Gülen T; Hägglund H; Dahlén B; Nilsson G
J Intern Med; 2016 Mar; 279(3):211-28. PubMed ID: 26347286
[TBL] [Abstract][Full Text] [Related]
60. Mast cell-restricted tetramer-forming tryptases and their beneficial roles in hemostasis and blood coagulation.
Prieto-García A; Castells MC; Hansbro PM; Stevens RL
Immunol Allergy Clin North Am; 2014 May; 34(2):263-81. PubMed ID: 24745673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
